CD4 and tuberculosis: In 2013, WHO guidelines recommended expanding ART eligibility to all HIV-positive persons with CD4+ counts <500 and persons with CD4>500 who have tuberculosis or hepatitis B, pregnant or breastfeeding women, and persons in serodiscordant partnerships.